Dyax Corp. Issued Sixth U.S. Patent in Its Phage Display Patent Portfolio
13 Oct 2006 -
Dyax Corp. announced that the United States Patent and Trademark office issued U.S. Patent No. 7,118,879, Dyax's sixth U.S. patent covering its proprietary phage display technology. This new patent provides Dyax with additional patent claims that cover methods for selecting antibodies physically associated with filamentous phage. In addition to its six U.S. patents, Dyax holds several issued patents
for phage display in Canada, Israel, and Japan, with pending applications in other countries.
Additional information
Dyax Corp. Cambridge, MA, United States of America
Top
Contact
Print version
PDF version
Send article
RSS-Feed